Zeria Pharmaceutical Co (TSE:4559) Total Stockholders Equity: 円108,039 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4559 Zeria Pharmaceutical Co Ltd TSE:4559
71 GF Score
Price 円2,018.00
GF Value 円2,487.46
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zeria Pharmaceutical Co Total Stockholders Equity?

Zeria Pharmaceutical Co TSE:4559 -0.69% 71 Total Stockholders Equity is 円108,039 Mil as of Jun. 2026. GuruFocus rates TSE:4559 with a GF Score™ of 71/100 and a GF Value™ of 円2,487.46 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Zeria Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Jun. 2026 was 円108,039 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Zeria Pharmaceutical Co's Book Value per Share for the quarter that ended in Jun. 2026 was 円2,451.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Zeria Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.34.

Zeria Pharmaceutical Co  (TSE:4559) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Zeria Pharmaceutical Co's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(108039.173-0)/44.079398
=2,451.01

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Zeria Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(31278.39 + 5195.83) / 108039.173
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co Total Stockholders Equity Related Terms

Zeria Pharmaceutical Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Zeria Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co Total Stockholders Equity Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54,894.64 65,449.92 79,622.56 89,539.84 108,396.74

Zeria Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87,437.24 91,671.28 96,014.09 108,396.74 108,039.17
TSE:4559
71GF Score
Zeria Pharmaceutical Co Ltd TSE:4559
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of 円108,039 Mil mean?
Zeria Pharmaceutical Co (TSE:4559) has a Total Stockholders Equity of 円108,039 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's Total Stockholders Equity too high?
Zeria Pharmaceutical Co's current Total Stockholders Equity is 円108,039 Mil. Overall, Zeria Pharmaceutical Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's Total Stockholders Equity compare to ZTS?
Zeria Pharmaceutical Co's Total Stockholders Equity of 円108,039 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current Total Stockholders Equity is 円108,039 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,487.46, compared to a current price of 円2,018.00 — trading 18.9% below its estimated fair value. The current Total Stockholders Equity is 円108,039 Mil. Zeria Pharmaceutical Co's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current Total Stockholders Equity is 円108,039 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?

Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,018.00 is trading 18.9% below its estimated GF Value™ of 円2,487.46. GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4559:

  • Total Stockholders Equity: 円108,039 Mil
  • GF Value™: 円2,487.46 vs. price of 円2,018.00 (18.9% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeria Pharmaceutical Co Business Description

Address 10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
71GF Score

Get the complete analysis for TSE:4559

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,018.00
Price
円2,487.46
GF Value